Selvita Is A Leading Preclinical Contract Research Organizationcrobased In Polandwith Its Headquarters In Krakowfounded In 2007It Has Grown To Become One Of The Largest Cros In Europeemploying Over 900 Specialists And Operating Globally With Offices In Key Locations Such As Cambridgesan Franciscobostonzagreband Poznan The Company Offers Integrated Drug Discovery And Development Servicesincluding Early Stage Research In Medicinal Chemistry And Structural Biologyas Well As Preclinical Development Services Like In Vitro Pharmacology And Adme Dmpk Studiesselvita Specializes In Therapeutic Areas Such As Oncologyinfectious Diseasesinflammationand Fibrosisand Provides Regulatory Support Through Glp Gmp Certified Laboratorieswith A Focus On End To End Solutionsselvita Bridges The Gap From Early Discovery To Clinical Stage Development While Ensuring That Clients Retain Ownership Of Their Intellectual Propertythe Company Serves Over 700 Clientsincluding Pharmaceutical And Biotech Firmsand Is Publicly Traded On The Warsaw Stock Exchange
